Wu D - Search Results

1

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Chen Z, Zhou K, Xue J, Small A, Xiao G, Nguyen LXT, Zhang Z, Prince E, Weng H, Huang H, Zhao Z, Qing Y, Shen C, Li W, Han L, Tan B, Su R, Qin H, Li Y, Wu D, Gu Z, Ngo VN, He X, Chao J, Leung K, Wang K, Dong L, Qin X, Cai Z, Sheng Y, Chen Y, Wu X, Zhang B, Shi Y, Marcucci G, Qian Z, Xu M, Müschen M, Chen J, Deng X. Chen Z, et al. Among authors: wu x, wu d. Sci Transl Med. 2023 Mar 29;15(689):eabq8513. doi: 10.1126/scitranslmed.abq8513. Epub 2023 Mar 29. Sci Transl Med. 2023. PMID: 36989375 Free PMC article.

2

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome.

Wu L, Shi W, Li X, Chang C, Xu F, He Q, Wu D, Su J, Zhou L, Song L, Xiao C, Zhang Z. Wu L, et al. Among authors: wu d. J Transl Med. 2016 Mar 5;14:66. doi: 10.1186/s12967-016-0817-9. J Transl Med. 2016. PMID: 26944860 Free PMC article.

3

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.

Li X, Xu F, Wu LY, Zhao YS, Guo J, He Q, Zhang Z, Chang CK, Wu D. Li X, et al. Among authors: wu d, wu ly. Sci Rep. 2020 Jan 21;10(1):826. doi: 10.1038/s41598-019-55540-w. Sci Rep. 2020. PMID: 31964915 Free PMC article.

4

AHR signaling pathway reshapes the metabolism of AML/MDS cells and potentially leads to cytarabine resistance.

Jia Y, Guo J, Zhao Y, Zhang Z, Shi L, Fang Y, Wu D, Wu L, Chang C. Jia Y, et al. Among authors: wu d, wu l. Acta Biochim Biophys Sin (Shanghai). 2021 Mar 26;53(4):492-500. doi: 10.1093/abbs/gmab017. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33709099 Free article.

5

[Clinical analysis of neutrophil suppression caused by decitabine for the treatment of myelodysplastic syndromes].

Wu D, Li X, Chang C, Wu L, Su J, Zhang X, Zhou L, Song L, He Q, Xiao C, Zhang Z, Guo C. Wu D, et al. Among authors: wu l. Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):173-5. doi: 10.3760/cma.j.issn.0253-2727.2014.02.026. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24606665 Chinese. No abstract available.

6

Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.

Zhao Y, Wu D, Fei C, Guo J, Gu S, Zhu Y, Xu F, Zhang Z, Wu L, Li X, Chang C. Zhao Y, et al. Among authors: wu d, wu l. Haematologica. 2015 Feb;100(2):194-204. doi: 10.3324/haematol.2014.109769. Epub 2014 Oct 31. Haematologica. 2015. PMID: 25361944 Free PMC article.

7

Efficacy and toxicity of decitabine versus CHG regimen (low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor) in patients with higher risk myelodysplastic syndrome: a retrospective study.

Wu L, Li X, Chang C, Xu F, He Q, Wu D, Zhang Z, Su J, Zhou L, Song L, Chao X, Zhao Y. Wu L, et al. Among authors: wu d. Leuk Lymphoma. 2016;57(6):1367-74. doi: 10.3109/10428194.2015.1096351. Epub 2015 Nov 16. Leuk Lymphoma. 2016. PMID: 26397697

8

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome.

Zhang Z, Chang CK, He Q, Guo J, Tao Y, Wu LY, Xu F, Wu D, Zhou LY, Su JY, Song LX, Xiao C, Li X. Zhang Z, et al. Among authors: wu d, wu ly. Leuk Lymphoma. 2017 Apr;58(4):969-978. doi: 10.1080/10428194.2016.1219903. Epub 2016 Aug 11. Leuk Lymphoma. 2017. PMID: 27686004

9

TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes.

Chang CK, Zhao YS, Xu F, Guo J, Zhang Z, He Q, Wu D, Wu LY, Su JY, Song LX, Xiao C, Li X. Chang CK, et al. Among authors: wu d, wu ly. Br J Haematol. 2017 Feb;176(4):600-608. doi: 10.1111/bjh.14455. Epub 2016 Dec 16. Br J Haematol. 2017. PMID: 27984642 Free article.

10

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.

Xu F, Wu LY, He Q, Wu D, Zhang Z, Song LX, Zhao YS, Su JY, Zhou LY, Guo J, Chang CK, Li X. Xu F, et al. Among authors: wu d, wu ly. Sci Rep. 2017 Feb 21;7:43113. doi: 10.1038/srep43113. Sci Rep. 2017. PMID: 28220884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,169 results

Search Page

Filters